Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STING trial of levetiracetam versus valproic acid for first seizure in glioma
NL-OMON50617Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Brain tumor-related epilepsy (BTRE) and glioma comparing Keppra monotherapy with Depakine monotherapy (2 arms). Primary endpoint: Ongoing seizure freedom at 6 months. Started Feb 2018; status: recruiting.
02
Drugs
levetiracetamvalproic acid
03
Conditions
Brain tumor-related epilepsy (BTRE)glioma
Beyond the preview
Go deeper on NL-OMON50617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50617.